Alex Generous, PhD

St. Jude is at the forefront of creating tools to visualize and analyze genomic data.

Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.

St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.

St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.

St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.

St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.

St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.

Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease

Marcin Wlodarski, MD, PhD, was new to international humanitarian work prior to volunteering with SAFER Ukraine. “I learned so much I cannot every describe it in words,” he said.

Global health care providers gathered virtually for SAFER Conversations, a webinar created to share information and support to those working with Ukrainian children and families displaced by the war.